Skye Bioscience, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit and Redeemable Convertible Series B Preferred Stock (Detail Textuals)

Stockholders' Deficit and Redeemable Convertible Series B Preferred Stock (Detail Textuals)	1 Months Ended													3 Months Ended					9 Months Ended		12 Months Ended
	Mar. 31, 2016 $ / shares shares	Dec. 31, 2015 USD ($) $ / shares shares	Nov. 30, 2015 USD ($) $ / shares shares	Aug. 31, 2015 USD ($) $ / shares shares	Aug. 21, 2015 USD ($) $ / shares shares	Jul. 31, 2015 USD ($) shares	Jun. 30, 2015 USD ($) $ / shares shares	May 31, 2015 $ / shares shares	Apr. 30, 2015 USD ($) $ / shares shares	Mar. 31, 2015 $ / shares shares	Jan. 31, 2015 USD ($) $ / shares shares	Oct. 31, 2014 Investors shares	Aug. 31, 2014 USD ($) $ / shares shares	Sep. 30, 2016 USD ($) $ / shares shares	Mar. 31, 2016 USD ($)	Sep. 30, 2015 USD ($) $ / shares shares	Mar. 31, 2015 USD ($) $ / shares shares	Dec. 31, 2014 USD ($)	Sep. 30, 2016 USD ($) $ / shares shares	Sep. 30, 2015 USD ($) $ / shares shares	Dec. 31, 2015 USD ($) $ / shares	Jun. 30, 2014 USD ($) shares	Jul. 17, 2012 Advisors $ / shares shares
Equity [Line Items]
Number of shares called by warrants \| shares									100,000
Warrant exercise price (in dollars per share) \| $ / shares									$ 5
Term of warrant									10 years
Value of common stock called by warrants \| $														$ 85,950					$ 85,950
Amortization of warrant service cost \| $																			$ 5,145	$ 46,810
Number of shares issued for services \| shares												1,110,000
Amortized general and administrative expense \| $															$ 12,194
Fair market value of common stock issued recorded as prepaid expense \| $																	$ 168,000
Number of shares issued to group of private investors \| shares										24,000	241,663
Value of shares issued to group of private investors \| $											$ 724,989
Par value of common stock issued (in dollars per share) \| $ / shares		$ 0.001								$ 0.001	$ 0.001			$ 0.001			$ 0.001		$ 0.001		$ 0.001
Number of individual investor \| Investors												18
General and administrative expense \| $														$ 775,623		$ 744,004		$ 466,200	$ 2,882,682	$ 2,929,799
Preferred stock, shares authorized \| shares														20,000,000					20,000,000
Preferred stock, par value (in dollars per share) \| $ / shares														$ 0.001					$ 0.001
Series A preferred stock
Equity [Line Items]
Number of shares issued to group of private investors \| shares						180,000		150,000	250,000
Preferred stock, par value (in dollars per share) \| $ / shares									$ 0.001
Minimum equity financing under down-round protection feature \| $						$ 286,000			$ 1,000,000										$ 1,000,000
Maximum common stock issuance price per share (in dollars per share) \| $ / shares									$ 2.50					$ 2.50					$ 2.50
Conversion price \| $ / shares				$ 2.50
Number of shares converted \| shares				580,000	580,000
Number of shares issued in conversion \| shares				1,812,500
Series B Preferred Stock
Equity [Line Items]
Number of preferred stock and warrants sold \| shares				5,000
Maximum common stock issuance price per share (in dollars per share) \| $ / shares				$ 1,000
Conversion price \| $ / shares	$ 0.80	$ 0.80		$ 0.80	$ 2.50
Number of shares converted \| shares	8	500		5,615,000
Number of shares issued in conversion \| shares	10,000	625,000		1,812,500
Proceeds received from the Series B financing \| $				$ 5,000,000	$ 5,000,000
Share price (in dollars per share) \| $ / shares				$ 1,000
Preferred stock, redemption terms				(A) 115% of the conversion amount and (B) the product of (1) the conversion rate in effect at such time and (2) the greatest closing sale price of the Common Stock during the period beginning on the date immediately preceding such triggering event and ending on the date such holder delivers the notice of redemption.
Preferred stock, conversion rate		1,250:1
Liquidation preference value \| $		$ 4,500,000		$ 4,500,000										$ 4,500,000					$ 4,500,000		$ 4,500,000
General and administrative expense
Equity [Line Items]
Value of common stock called by warrants \| $									$ 326,000
Warrants
Equity [Line Items]
Number of shares called by warrants \| shares			120,000	6,250,000			10,000	90,000	6,000	90,000			2,200,000			10,000	90,000			10,000			3,000,000
Warrant exercise price (in dollars per share) \| $ / shares			$ 1.15	$ 1.15			$ 5.00	$ 2.50	$ 2.50	$ 2.50						$ 5.00	$ 2.50			$ 5.00			$ 1.00
Term of warrant			5 years	5 years			5 years			5 years
Number of advisors \| Advisors																							2
Value of common stock called by warrants \| $			$ 42,000	$ 86,250			$ 14,700		$ 10,000				$ 1,100,000			$ 14,700				$ 14,700
Amortization of warrant service cost \| $																			34,200		$ 7,800
Number of shares issued to group of private investors \| shares				187,500		36,000		30,000	50,000
Value of warrants issued \| $				$ 1,000					$ 625,000
Number of shares vested \| shares			60,000
Minimum equity financing under down-round protection feature \| $																			$ 1,000,000
Maximum common stock issuance price per share (in dollars per share) \| $ / shares														$ 2.50					$ 2.50
Warrants \| Series A preferred stock
Equity [Line Items]
Number of shares called by warrants \| shares									50,000
Warrant exercise price (in dollars per share) \| $ / shares									$ 5.00
Term of warrant									5 years
Warrants \| June 2014 Stock Purchase Agreement
Equity [Line Items]
Number of shares called by warrants \| shares													450,000	550,000					550,000			1,800,000
Warrant exercise price (in dollars per share) \| $ / shares													$ 1.00	$ 1.00					$ 1.00
Value of common stock called by warrants \| $																						$ 900,000
Value of warrants issued \| $													$ 85,500						$ 104,500
Common Stock
Equity [Line Items]
Conversion price \| $ / shares				$ 0.80
Number of shares converted \| shares				1,250